[Federal Register Volume 78, Number 204 (Tuesday, October 22, 2013)]
[Notices]
[Pages 62765-62766]
[FR Doc No: 2013-24663]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-70671; File No. SR-BOX-2013-46]

Self-Regulatory Organizations; BOX Options Exchange LLC; Notice
of Filing and Immediate Effectiveness of a Proposed Rule Change To
Amend BOX Rule 3130 (Exemptions From Position Limits)

October 11, 2013.
    Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934
(``Act''),\1\ and Rule 19b-4 thereunder,\2\ notice is hereby given that
on October 2, 2013, BOX Options Exchange LLC (the ``Exchange'') filed
with the Securities and Exchange Commission (``Commission'') the
proposed rule change as described in Items I and II below, which Items
have been prepared by the self-regulatory organization. The Commission
is publishing this notice to solicit comments on the proposed rule
change from interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    The Exchange proposes to amend BOX Rule 3130 (Exemptions from
Position Limits) to simplify the position limit exemptions available to
Options Participants. The text of the proposed rule change is available
from the principal office of the Exchange, at the Commission's Public
Reference Room and also on the Exchange's Internet Web site at http://boxexchange.com.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, the self-regulatory organization
included statements concerning the purpose of, and basis for, the
proposed rule change and discussed any comments it received on the
proposed rule change. The text of these statements may be examined at
the places specified in Item IV below. The self-regulatory organization
has prepared summaries, set forth in Sections A, B, and C below, of the
most significant aspects of such statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

1. Purpose
    The Exchange proposes to amend BOX Rule 3130 (Exemptions from
Position Limits) to simplify the position limit exemptions available to
Options Participants. This is a competitive filing based on the rules
of BX and BATS.\3\
---------------------------------------------------------------------------

    \3\ See BX Chapter XIV, Section 8 and BATS Rule 18.8.
---------------------------------------------------------------------------

    Specifically, the Exchange proposes to remove sections (b) through
(e) of BOX Rule 3130. Once removed, section (a), ``Exemption Granted by
Other Exchanges,'' will be the sole position limit exemption remaining.
The Exchange believes that this exemption, which allows Participants to
rely on applicable position limit exemptions granted by other
exchanges, will result in increased uniformity among the exchanges and
cause less confusion among all market participants. Furthermore the
proposed change will have no impact on the position limit exemptions
currently used by Participants on BOX. The Exchange has reviewed the
position limit exemptions available at the other option exchanges and
believes these represent all position limit exemptions that the
Exchange is seeking to remove. The Exchange notes that this proposed
change mimics the position limit exemption language used by BX and
BATS.\4\ In addition, the Exchange believes that the proposed rule
change will help ensure that the Exchange's rules regarding Exemptions
from Position Limits will always be in alignment with FINRA's exemption
rules,\5\ even if these change from time to time.
---------------------------------------------------------------------------

    \4\ Id.
    \5\ See FINRA Rule 2360(b)(3)(A)(vii).
---------------------------------------------------------------------------

2. Statutory Basis
    The Exchange believes that the proposal is consistent with the

requirements of Section 6(b) of the Securities Exchange Act of 1934
(the ``Act''),\6\ in general, and Section 6(b)(4) of the Act,\7\ in
particular, in that it is designed to prevent fraudulent and
manipulative acts and practices, to promote just and equitable
principles of trade, to foster cooperation and coordination with
persons engaged in facilitating transactions in securities, to remove
impediments to and perfect the mechanism of a free and open market and
a national market system, and, in general to protect investors and the
public interest.
---------------------------------------------------------------------------

    \6\ 15 U.S.C. 78f(b).
    \7\ 15 U.S.C. 78f(b)(4).
---------------------------------------------------------------------------

    In particular, the Exchange believes the proposed rule change will
provide greater clarity to market participants regarding the Exchange's
rules. In addition, the Exchange believes that the proposed rule change
will help ensure that the Exchange's rules regarding Exemptions from
Position Limits will always be in alignment with FINRA's rules.
Accordingly, this proposal is designed to harmonize the exemptions from
position limits rules across exchanges and will help protect investors.

B. Self-Regulatory Organization's Statement on Burden on Competition

    The Exchange does not believe that the proposed rule change will
impose any burden on competition not necessary or appropriate in
furtherance of the purposes of the Act. In this regard and as indicated
above, the Exchange notes that the rule change being proposed is
substantially similar to BX's and BATS's rules regarding Exemptions
from Position Limits.\8\
---------------------------------------------------------------------------

    \8\ See supra, note 3.
---------------------------------------------------------------------------

    The Exchange believes this proposed rule change is necessary to
establish uniform rules regarding Exemptions from Position Limits.
Specifically, the proposed rule change will bring clarity and
consistency to Exchange Rules by harmonizing the exemptions from
position limits rules across exchanges and will therefore help protect
investors. The Exchange does not believe the proposed rule change will
impose any burden on any intramarket competition as it applies to all
Participants. In addition, the Exchange does not believe the proposed
rule filing will bring any unnecessary burden on intermarket
competition as it is consistent with the ``Exemption from Position
Limits'' rules of BX and BATS.\9\
---------------------------------------------------------------------------

    \9\ See supra, note 3.
---------------------------------------------------------------------------

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants, or Others

    The Exchange has neither solicited nor received comments on the
proposed rule change.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    Because the proposed rule change does not (i) significantly affect
the protection of investors or the public interest; (ii) impose any
significant burden on competition; and (iii) become operative for 30
days from the date on which it was filed, or such shorter time as the
Commission may designate if consistent with the protection of investors
and the public interest, the proposed rule change has become effective
pursuant to Section 19(b)(3)(A) of the Act \10\ and Rule 19b-4(f)(6)
thereunder.\11\ At any time within 60 days of the filing of such
proposed rule change, the Commission summarily may temporarily suspend
such rule change if it appears to the Commission that such action is
necessary or appropriate in the public interest, for the protection of
investors, or otherwise in furtherance of the purposes of the Act.
---------------------------------------------------------------------------

    \10\ 15 U.S.C. 78s(b)(3)(A).
    \11\ 17 CFR 240.19b-4(f)(6). As required under Rule 19b-
4(f)(6)(iii), the Exchange provided the Commission with written
notice of its intent to file the proposed rule change, along with a
brief description and the text of the proposed rule change, at least
five business days prior to the date of filing of the proposed rule
change, or such shorter time as designated by the Commission.
---------------------------------------------------------------------------

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://www.sec.gov/rules/sro.shtml ); or
     Send an email to<EMAIL_ADDRESS>Please include
File Number SR-BOX-2013-46 on the subject line.

Paper Comments

     Send paper comments in triplicate to Elizabeth M. Murphy,
Secretary, Securities and Exchange Commission, 100 F Street NE.,
Washington, DC 20549-1090.

All submissions should refer to File Number SR-BOX-2013-46. This file
number should be included on the subject line if email is used. To help
the Commission process and review your comments more efficiently,
please use only one method. The Commission will post all comments on
the Commission's Internet Web site (http://www.sec.gov/rules/sro.shtml
). Copies of the submission, all subsequent amendments, all written
statements with respect to the proposed rule change that are filed with
the Commission, and all written communications relating to the proposed
rule change between the Commission and any person, other than those
that may be withheld from the public in accordance with the provisions
of 5 U.S.C. 552, will be available for Web site viewing and printing in
the Commission's Public Reference Room, 100 F Street NE., Washington,
DC 20549, on official business days between the hours of 10:00 a.m. and
3:00 p.m. Copies of the filing also will be available for inspection
and copying at the principal office of the Exchange. All comments
received will be posted without change; the Commission does not edit
personal identifying information from submissions. You should submit
only information that you wish to make available publicly. All
submissions should refer to File Number SR-BOX-2013-46 and should be
submitted on or before November 12, 2013.
---------------------------------------------------------------------------

    \12\ 17 CFR 200.30-3(a)(12).

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\12\
Kevin M. O'Neill,
Deputy Secretary.
[FR Doc. 2013-24663 Filed 10-21-13; 8:45 am]
BILLING CODE 8011-01-P


[Federal Register Volume 79, Number 233 (Thursday, December 4, 2014)]
[Notices]
[Pages 72104-72105]
[FR Doc No: 2014-28242]

Federal Register / Vol. 79, No. 233 / Thursday, December 4, 2014 /
Notices

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2014-D-1551]

Pregnancy, Lactation, and Reproductive Potential: Labeling for
Human Prescription Drug and Biological Products--Content and Format;
Draft Guidance for Industry; Availability

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the
availability of a draft guidance for industry entitled ``Pregnancy,
Lactation, and Reproductive Potential: Labeling for Human Prescription
Drug and Biological Products--Content and Format.'' This draft guidance
is intended to assist applicants in complying with the new content and
format requirements in the Pregnancy, Lactation, and Females and Males
of Reproductive Potential subsections of labeling for human
prescription drug and biological products, as described in the final
rule, Content and Format of Labeling for Human Prescription Drug and
Biological Products; Requirements for Pregnancy and Lactation Labeling.
The rule, which is being published concurrently with this draft
guidance, is referred to as the ``Pregnancy and Lactation Labeling
Rule'' (PLLR). The draft guidance will assist applicants in developing
labeling for new products, revising existing labeling, and implementing
the content and format requirements of the PLLR for human prescription
drug and biological products.

DATES: Although you can comment on any guidance at any time (see 21 CFR
10.115(g)(5)), to ensure that the Agency considers your comment on this
draft guidance before it begins work on the final version of the
guidance, submit either electronic or written comments on the draft
guidance by February 2, 2015.

ADDRESSES: Submit written requests for single copies of this draft
guidance to the Division of Drug Information, Center for Drug
Evaluation and Research, Food and Drug Administration, 10001 New
Hampshire Ave., Hillandale Bldg., 4th Floor, Silver Spring, MD 20993,
or Office of Communication, Outreach and Development, Center for
Biologics Evaluation and Research (CBER), Food and Drug Administration,
10903 New Hampshire Ave., Bldg. 71, Rm. G102, Silver Spring, MD 20993.
Send one self-addressed adhesive label to assist that office in
processing your requests. See the SUPPLEMENTARY INFORMATION section for
electronic access to the guidance document.
    Submit electronic comments on the draft guidance to http://www.regulations.gov. Submit written comments to the Division of Dockets
Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Division of Pediatric and Maternal
Health, Center for Drug Evaluation and Research, Food and Drug
Administration, 10903 New Hampshire Ave., Bldg. 22, Rm. 6312, Silver
Spring, MD 20993-0002,<PHONE_NUMBER>; or Stephen Ripley, Center for
Biologics Evaluation and Research, Food and Drug Administration, 10903
New Hampshire Ave., Bldg. 71, Rm. 7301, Silver Spring, MD 20993, 240-
402-7911.

SUPPLEMENTARY INFORMATION:

I. Background

    FDA is announcing the availability of a draft guidance for industry
entitled ``Pregnancy, Lactation, and Reproductive Potential: Labeling
for Human Prescription Drug and Biological Products--Content and
Format.'' The draft guidance provides recommendations on how to develop
and revise professional labeling that meets the new content and format
requirements of the Pregnancy, Lactation, and Females and Males of
Reproductive Potential subsections of labeling for human prescription
drug and biological products. Specifically, it provides information to
assist applicants in preparing subsections 8.1 Pregnancy, 8.2
Lactation, and 8.3 Females and Males of Reproductive Potential of the
USE IN SPECIFIC POPULATIONS section of the full prescribing information
under 21 CFR 201.56(d)(1) and 201.57(c)(9)(i) through (iii), as
described in the PLLR.
    The PLLR provides a framework to clearly communicate information on
the benefits and risks of drug use during pregnancy and lactation to
help facilitate prescribing decisions. The PLLR also includes a
subsection on females and males of reproductive potential to address
issues in these populations that are linked to pregnancy either
directly or indirectly. The draft guidance provides recommendations to
applicants submitting new drug applications (NDAs), efficacy
supplements to approved NDAs, biologics license applications (BLAs)
(for biological products that are regulated as drugs), and efficacy
supplements to BLAs, as well as to applicants that have previously
submitted such applications during the time periods specified in the
implementation plan set out in the preamble to the PLLR. FDA may revise
other Agency guidances as needed and appropriate to reflect the PLLR
content and format requirements and the recommendations in this
guidance, once it has been finalized.
    This draft guidance is one of a series of guidances FDA is
developing, or has developed, to assist applicants with the content and
format of the labeling for human prescription drug and biological
products. In the Federal Register of January 24, 2006 (71 FR 3999), FDA
announced the availability of final guidances on the content and format
of the ``Adverse Reactions'' (http://www.fda.gov/downloads/Drugs/
GuidanceComplianceRegulatoryInformation/Guidances/ucm075057.pdf) and
``Clinical Studies'' (http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm075059.pdf)
sections of labeling. In the Federal Register of October 19, 2009 (74
FR 53507), FDA announced the availability of final guidance on
determining established pharmacologic class for use in the ``Highlights
of Prescribing Information'' (http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM186607.pdf). In
the Federal Register of March 23, 2010 (75 FR 13766), FDA announced the
availability of final guidance on the content and format of the
``Dosage and Administration'' section of labeling (http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM075066.pdf). In the Federal Register of October 12, 2011 (76 FR
63303), FDA announced the availability of final guidance on the content
and format of the ``Warnings and Precautions,'' ``Contraindications,''
and ``Boxed Warning'' sections of labeling (http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM075096.pdf),and in the Federal Register of March 3, 2009 (74 FR
9250), FDA announced the availability of draft guidance on the content
and format of the ``Clinical Pharmacology'' section of labeling (http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM109739.pdf). In the Federal Register of February 25, 2013
(78 FR 12760), FDA announced the availability

of final guidance implementing the ``Physician Labeling Rule'' (January
24, 2006, 71 FR 3922) content and format requirements of labeling for
human prescription drug and biological products under Sec. Sec.
201.56(d) and 201.57 (http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm075082.pdf). In
the Federal Register of February 28, 2013 (78 FR 13686), FDA announced
the availability of draft guidance on the placement and content of
pediatric information in the labeling for human prescription drug and
biological products in accordance with the Physician Labeling Rule
(http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM341394.pdf).
    The labeling requirements and these guidances are intended to make
information in prescription drug labeling easier for health care
practitioners to access, read, and use.
    This draft guidance is being issued consistent with FDA's good
guidance practices regulation (21 CFR 10.115). The draft guidance, when
finalized, will represent the Agency's current thinking on implementing
the PLLR content and format requirements for labeling for human
prescription drug and biological products. It does not create or confer
any rights for or on any person and does not operate to bind FDA or the
public. An alternative approach may be used if such approach satisfies
the requirements of the applicable statutes and regulations.

II. Comments

    Interested persons may submit either electronic comments regarding
this document to http://www.regulations.gov or written comments to the
Division of Dockets Management (see ADDRESSES). It is only necessary to
send one set of comments. Identify comments with the docket number
found in brackets in the heading of this document. Received comments
may be seen in the Division of Dockets Management between 9 a.m. and 4
p.m., Monday through Friday, and will be posted to the docket at http://www.regulations.gov.

III. Paperwork Reduction Act of 1995

    This guidance refers to previously approved collections of
information that are subject to review by the Office of Management and
Budget (OMB) under the Paperwork Reduction Act of 1995 (44 U.S.C. 3501-
3520). The collection of information in 21 CFR 201.56 and 201.57 has
been approved under OMB control number 0910-0572. The collection of
information in 21 CFR 314.70 and 314.97 for submitting supplements to
an approved application, the collection of information in 21 CFR
314.50(e) for submitting labeling for an application, and the
collection of information in 21 CFR 314.90 for submitting waiver
requests for an application have been approved under OMB control number
0910-0001. The collection of information in 21 CFR 601.12 for
submitting supplements to an approved application has been approved
under OMB control number 0910-0338. In addition, the information
collection provisions of the PLLR have been submitted to OMB for
review, as required by section 3507(d) of the Paperwork Reduction Act.
Prior to the effective date of the PLLR, FDA will publish a notice in
the Federal Register announcing OMB's decision to approve, modify, or
disapprove the information collection provisions in the final rule.

IV. Electronic Access

    Persons with access to the Internet may obtain the draft guidance
at either http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm, http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/default.htm, or http://www.regulations.gov.

    Dated: November 25, 2014.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2014-28242 Filed 12-3-14; 8:45 am]
BILLING CODE 4164-01-P


[Federal Register Volume 79, Number 84 (Thursday, May 1, 2014)]
[Notices]
[Pages 24701-24702]
[FR Doc No: 2014-09974]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings 1

    Take notice that the Commission received the following electric
rate filings:

    Docket Numbers: ER10-3300-004.
    Applicants: La Paloma Generating Company, LLC.
    Description: La Paloma Generating Company, LLC Supplement to June
25, 2013 Triennial Updated Market Power Analysis for the Southwest
Region.
    Filed Date: 4/23/14.
    Accession Number: 20140423-5198.
    Comments Due: 5 p.m. ET 5/14/14.

    Docket Numbers: ER14-271-001.
    Applicants: El Paso Electric Company.
    Description: Removal of Rate Schedule No. 112 Nonconforming Firm
PTP Svc Agreement w/PNM to be effective 1/1/2014.
    Filed Date: 4/24/14.
    Accession Number: 20140424-5043.
    Comments Due: 5 p.m. ET 5/15/14.

    Docket Numbers: ER14-1761-000.
    Applicants: American Electric Power Service Corporation.
    Description: Notice of Cancellation of American Electric Power
Service Corporation on Behalf of AEP Energy Partners, Inc.
    Filed Date: 4/23/14.
    Accession Number: 20140423-5205.
    Comments Due: 5 p.m. ET 5/14/14.

    Docket Numbers: ER14-1762-000.
    Applicants: American Electric Power Service Corporation.
    Description: Notice of Cancellation of American Electric Power
Service Corporation on Behalf of CSW Energy Services, Inc.
    Filed Date: 4/23/14.
    Accession Number: 20140423-5206.
    Comments Due: 5 p.m. ET 5/14/14.

    Docket Numbers: ER14-1764-000.
    Applicants: American Electric Power Service Corporation.
    Description: Notice of Cancellation of American Electric Power
Service Corporation on Behalf of the AEP Operating Companies.
    Filed Date: 4/23/14.
    Accession Number: 20140423-5208.
    Comments Due: 5 p.m. ET 5/14/14.

    Docket Numbers: ER14-1765-000.
    Applicants: PJM Interconnection, L.L.C.
    Description: Queue No. Z2-027; Original Service Agreement Nos. 3802
and 3803 to be effective 3/28/2014.
    Filed Date: 4/24/14.
    Accession Number: 20140424-5033.
    Comments Due: 5 p.m. ET 5/15/14.

    Docket Numbers: ER14-1766-000.
    Applicants: American Electric Power Service Corporation.
    Description: Notice of Cancellation of American Electric Power
Service Corporation on behalf of CSW Operating Companies.
    Filed Date: 4/24/14.
    Accession Number: 20140424-5080.
    Comments Due: 5 p.m. ET 5/15/14.

    Docket Numbers: ER14-1767-000.
    Applicants: Titan Gas and Power.
    Description: MBR Tariff to be effective 6/23/2014.
    Filed Date: 4/24/14.
    Accession Number: 20140424-5138.
    Comments Due: 5 p.m. ET 5/15/14.

    The filings are accessible in the Commission's eLibrary system by

clicking on the links or querying the docket number.
    Any person desiring to intervene or protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Regulations (18 CFR 385.211 and 385.214) on or before 5:00
p.m. Eastern time on the specified comment date. Protests may be
considered, but intervention is necessary to become a party to the
proceeding.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.

    Dated: April 24, 2014.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2014-09974 Filed 4-30-14; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 78, Number 236 (Monday, December 9, 2013)]
[Proposed Rules]
[Pages 73749-73750]
[FR Doc No: 2013-29241]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 71

[Docket No. FAA-2013-0917; Airspace Docket No. 13-ACE-16]

Proposed Amendment of Class D Airspace; St. Joseph, MO

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Notice of proposed rulemaking (NPRM).

-----------------------------------------------------------------------

SUMMARY: This action proposes to amend Class D airspace at St. Joseph,
MO. Additional controlled airspace is necessary to accommodate new
Standard Instrument Approach Procedures (SIAP) at Rosecrans Municipal
Airport. The FAA is taking this action to enhance the safety and
management of Instrument Flight Rules (IFR) operations for SIAPs at the
airport.

DATES: Comments must be received on or before January 23, 2014.

ADDRESSES: Send comments on this proposal to the U.S. Department of
Transportation, Docket Operations, 1200 New Jersey Avenue SE., West
Building Ground Floor, Room W12-140, Washington, DC 20590-0001. You
must identify the docket number FAA-2013-0917/Airspace Docket No. 13-
ACE-16, at the beginning of your comments. You may also submit comments
through the Internet at http://www.regulations.gov. You may review the
public docket containing the proposal, any comments received, and any
final disposition in person in the Dockets Office between 9:00 a.m. and
5:00 p.m., Monday through Friday, except Federal holidays. The Docket
Office telephone 1-800-647-5527, is on the ground floor of the building
at the above address.

FOR FURTHER INFORMATION CONTACT: Scott Enander, Central Service Center,
Operations Support Group, Federal Aviation Administration, Southwest
Region, 2601 Meacham Blvd., Fort Worth, TX 76137; telephone: 817-321-
7716.

SUPPLEMENTARY INFORMATION:

Comments Invited

    Interested parties are invited to participate in this proposed
rulemaking by submitting such written data, views, or arguments, as
they may desire. Comments that provide the factual basis supporting the
views and suggestions presented are particularly helpful in developing
reasoned regulatory decisions on the proposal. Comments are
specifically invited on the overall regulatory, aeronautical, economic,
environmental, and energy-related aspects of the proposal.
Communications should identify both docket numbers and be submitted in
triplicate to the address listed above. Commenters wishing the FAA to
acknowledge receipt of their comments on this notice must submit with
those comments a self-addressed, stamped postcard on which the
following statement is made: ``Comments to Docket No. FAA-2013-0917/
Airspace Docket No. 13-ACE-16.'' The postcard will be date/time stamped
and returned to the commenter.

Availability of NPRMs

    An electronic copy of this document may be downloaded through the
Internet at http://www.regulations.gov. Recently published rulemaking
documents can also be accessed through the FAA's Web page at http://www.faa.gov/airports_airtraffic/air_traffic/publications/airspace_amendments/.
    You may review the public docket containing the proposal, any
comments received and any final disposition in person in the Dockets
Office (see ADDRESSES section for address and phone number) between
9:00 a.m. and 5:00 p.m., Monday through Friday, except Federal
holidays. An informal docket may also be examined during normal
business hours at the office of the Central Service Center, 2601
Meacham Blvd., Fort Worth, TX 76137.
    Persons interested in being placed on a mailing list for future
NPRMs should contact the FAA's Office of Rulemaking<PHONE_NUMBER>, to
request a copy of Advisory Circular No. 11-2A, Notice of Proposed
Rulemaking Distribution System, which describes the application
procedure.

The Proposal

    This action proposes to amend Title 14, Code of Federal Regulations
(14 CFR), Part 71 by amending Class D airspace to accommodate new
standard instrument approach procedures at Rosecrans Municipal Airport,
St. Joseph, MO. Accordingly, additional segments would extend from the
4.3-mile radius of the airport to 4.9 miles northwest and 4.5 miles
southeast of the airport, to retain the safety and management of IFR
aircraft in Class E airspace to/from the en route environment.
    Class D airspace areas are published in Paragraph 5000 of FAA Order
7400.9X, dated August 7, 2013 and effective September 15, 2013, which
is incorporated by reference in 14 CFR 71.1. The Class D airspace
designation listed in this document would be published subsequently in
the Order.
    The FAA has determined that this proposed regulation only involves
an established body of technical regulations for which frequent and
routine amendments are necessary to keep them operationally current.
It, therefore, (1) is not a ``significant regulatory action'' under
Executive Order 12866; (2) is not a ``significant rule'' under DOT
Regulatory Policies and Procedures (44 FR 11034; February 26, 1979);
and (3) does not warrant preparation of a Regulatory Evaluation as the
anticipated impact is so minimal. Since this is a routine matter that
will only affect air traffic procedures and air navigation, it is
certified that this rule, when promulgated, will not have a significant
economic impact on a substantial number of small entities under the
criteria of the Regulatory Flexibility Act.
    The FAA's authority to issue rules regarding aviation safety is
found in Title 49 of the U.S. Code. Subtitle 1, Section 106 describes
the authority of the FAA Administrator. Subtitle VII, Aviation
Programs, describes in more detail the scope of the agency's authority.
This rulemaking is promulgated under the authority described in
Subtitle VII, Part A, Subpart I, Section 40103. Under that section, the
FAA is charged with prescribing regulations to assign the use of
airspace necessary to ensure the safety of aircraft and the efficient
use of airspace. This regulation is within the scope of that authority
as it would amend controlled airspace at Rosecrans Municipal Airport,
St. Joseph, MO.

Environmental Review

    This proposal will be subject to an environmental analysis in
accordance with FAA Order 1050.1E, ``Environmental Impacts: Policies
and Procedures'' prior to any FAA final regulatory action.

List of Subjects in 14 CFR Part 71

    Airspace, Incorporation by reference, Navigation (air).

The Proposed Amendment

    In consideration of the foregoing, the Federal Aviation
Administration proposes to amend 14 CFR Part 71 as follows:

PART 71--DESIGNATION OF CLASS A, B, C, D, AND E AIRSPACE AREAS; AIR
TRAFFIC SERVICE ROUTES; AND REPORTING POINTS

0
1. The authority citation for part 71 continues to read as follows:

    Authority:  49 U.S.C. 106(g); 40103, 40113, 40120; E.O. 10854,
24 FR 9565, 3 CFR, 1959-1963 Comp., p. 389.

Sec.  71.1  [Amended]

0
2. The incorporation by reference in 14 CFR 71.1 of FAA Order 7400.9X,
Airspace Designations and Reporting Points, dated August 7, 2013, and
effective September 15, 2013, is amended as follows:

Paragraph 5000 Class D Airspace.

* * * * *

ACE MO D St. Joseph, MO [Amended]

St. Joseph, Rosecrans Memorial Airport, MO
    (Lat. 39[deg]46'19'' N., long. 94[deg]54'35'' W.)

    That airspace extending upward from the surface to and including
3,300 feet MSL within a 4.3-mile radius of Rosecrans Memorial
Airport, and within 1.2 miles each side of the 136[deg] bearing from
the airport extending from the 4.3-mile radius to 4.5 miles
southeast of the airport, and within 1.2 miles each side of the
316[deg] bearing from the airport extending from the 4.3-mile radius
to 4.9 miles northwest of the airport. This Class D airspace area is
effective during the specific dates and times established in advance
by a Notice to Airmen. The effective date and time will thereafter
be continuously published in the Airport/Facility Directory.

    Issued in Fort Worth, TX, on November 25, 2013.
David P. Medina,
Manager, Operations Support Group, ATO Central Service Center.
[FR Doc. 2013-29241 Filed 12-6-13; 8:45 am]
BILLING CODE 4901-13-P